Spironolactone "safer first-line" therapy for hypertension

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1254, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

-Blockers: "not appropriate" first-line therapy for hypertension

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Combination Therapy as First-Line Treatment for Hypertension

By Crawford Michael H.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

ACE inhibitors not worth it as first-line therapy in hypertension

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite